- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 384-398 of
901 results
2009 Exhibit: EX2009 Joint Stipulation and Order Amending Scheduling Order, In r...
Document
IPR2024-00009, No. 2009 Exhibit - EX2009 Joint Stipulation and Order Amending Scheduling Order, In re Ozempic Semaglutide Patent Litigation, MDL No 22 MD 03038 CFC, Dkt 268 D Del Dec...
|
|
Cite Document
1027 Exhibit: Holst, Truncated Glucagon like Peptide I, 211 2 FEBS LETTERS 169 ...
Document
IPR2024-00009, No. 1027 Exhibit - Holst, Truncated Glucagon like Peptide I, 211 2 FEBS LETTERS 169 1987 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1060 Exhibit: WO 2011058193
Document
IPR2024-00009, No. 1060 Exhibit - WO 2011058193 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1024 Exhibit: Drucker, The Incretin System, 368 LANCET 1696 2006
Document
IPR2024-00009, No. 1024 Exhibit - Drucker, The Incretin System, 368 LANCET 1696 2006 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1069 Exhibit: REMINGTON, THE SCIENCPRACTICE, Alfonso R Gennaro ed, 20th e...
Document
IPR2024-00009, No. 1069 Exhibit - REMINGTON, THE SCIENCPRACTICE, Alfonso R Gennaro ed, 20th ed 2000 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1020 Exhibit: Bydureon prescribing information Jan 2012
Document
IPR2024-00009, No. 1020 Exhibit - Bydureon prescribing information Jan 2012 (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1091 Exhibit: Declaration of Dr Russell M Zusman
Document
IPR2024-00009, No. 1091 Exhibit - Declaration of Dr Russell M Zusman (P.T.A.B. Oct. 20, 2023)
|
|
Cite Document
1093 Exhibit: Beel Declaration
Document
IPR2023-00724, No. 1093 Exhibit - Beel Declaration (P.T.A.B. Dec. 18, 2023)
|
|
Cite Document
2362 Exhibit: EX2362 US Food Drug Administration, DrugsFDA, Diabeta®
Document
IPR2023-00724, No. 2362 Exhibit - EX2362 US Food Drug Administration, DrugsFDA, Diabeta® (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2387 Exhibit: EX2387 American Heart Association, “Cardiovascular Disease and D...
Document
IPR2023-00724, No. 2387 Exhibit - EX2387 American Heart Association, “Cardiovascular Disease and Diabetes,” httpswwwheartorgenhealth topicsdiabetesdiabetes complications and riskscar...
|
|
Cite Document
2015 Exhibit: EX2015 Shaman, A, et al, “Effect of the Glucagon Like Peptide 1 Rec...
Document
IPR2023-00724, No. 2015 Exhibit - EX2015 Shaman, A, et al, “Effect of the Glucagon Like Peptide 1 Receptor Agonists Semaglutide and Liraglutide on Kidney Outcomes in Patients With Type 2...
|
|
Cite Document
2442 Exhibit: EX2442 Invokamet® Prescribing Information rev Aug 2017
Document
IPR2023-00724, No. 2442 Exhibit - EX2442 Invokamet® Prescribing Information rev Aug 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
2393 Exhibit: EX2393 DiBonaventura, Md, et al, Multinational Internet based surve...
Document
IPR2023-00724, No. 2393 Exhibit - EX2393 DiBonaventura, Md, et al, Multinational Internet based survey of patient preference for newer oral or injectable Type 2 diabetes medication, Patient P...
|
|
Cite Document
2478 Exhibit: EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investope...
Document
IPR2023-00724, No. 2478 Exhibit - EX2478 Chen, J, Blockbuster Drug What it is, How it works, Investopedia, httpswwwinvestopediacomtermsbblockbuster drugasp, last updated Sept 6, 2022 (P...
|
|
Cite Document
2468 Exhibit: EX2468 Stegluromet Prescribing Information rev Dec 2017
Document
IPR2023-00724, No. 2468 Exhibit - EX2468 Stegluromet Prescribing Information rev Dec 2017 (P.T.A.B. Jan. 17, 2024)
|
|
Cite Document
